Skip to main content
. 2018 Feb 8;8(1):25–34. doi: 10.1159/000486848

Table 2.

Differentiating features of C3 glomerulopathy and aHUS

C3 glomerulopathy aHUS
Clinical features Hematuria, proteinuria, renal failure Hematuria, proteinuria, renal failure, thrombocytopenia and anemia

Multi-system involvement No Yes

Laboratory parameters Proteinuria, hematuria, increased BUN and Cr, low GFR Proteinuria, hematuria, increased BUN and Cr, low GFR
Thrombocytopenia (relative or absolute), anemia, low haptoglobin, elevated LDH, schistocytes on peripheral smear can be observed

ADAMTS-13 At present no role in establishing the diagnosis Important in establishing the diagnosis

Renal biopsy Required to make the diagnosis Not required to make the diagnosis

Pathophysiology Alternate complement pathway dysregulation (fluid phase) Alternate complement pathway dysregulation (solid phase)

Prognosis Relatively better prognosis Worse prognosis with high recurrence

Treatment Role of complement pathway blockade is controversial Role of complement blockade established

aHUS, atypical hemolytic uremic syndrome; BUN, blood urea nitrogen; Cr, creatinine; GFR, glomerular filtration rate; LDH, lactate dehydrogenase.